Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Biohaven Pharmaceutical Holding Company stock

Own Biohaven Pharmaceutical Holding Company stock in just a few minutes.

Biohaven Pharmaceutical Holding Company Ltd is a biotechnology business based in the US. Biohaven Pharmaceutical Holding Company shares (BHVN) are listed on the NYSE and all prices are listed in US Dollars. Biohaven Pharmaceutical Holding Company employs 825 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Biohaven Pharmaceutical Holding Company

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BHVN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biohaven Pharmaceutical Holding Company share price

Use our graph to track the performance of BHVN stocks over time.

Biohaven Pharmaceutical Holding Company shares at a glance

Information last updated 2021-04-30.
52-week range$42.74 - $100.77
50-day moving average $72.19
200-day moving average $82.01
Wall St. target price$102.18
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-9.14

Buy Biohaven Pharmaceutical Holding Company shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biohaven Pharmaceutical Holding Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biohaven Pharmaceutical Holding Company financials

Revenue TTM $63.6 million
Gross profit TTM $45.9 million
Return on assets TTM -78.23%
Return on equity TTM 0%
Profit margin 0%
Book value $2.09
Market capitalisation $4.9 billion

TTM: trailing 12 months

Shorting Biohaven Pharmaceutical Holding Company shares

There are currently 5.3 million Biohaven Pharmaceutical Holding Company shares held short by investors – that's known as Biohaven Pharmaceutical Holding Company's "short interest". This figure is 17.6% down from 6.5 million last month.

There are a few different ways that this level of interest in shorting Biohaven Pharmaceutical Holding Company shares can be evaluated.

Biohaven Pharmaceutical Holding Company's "short interest ratio" (SIR)

Biohaven Pharmaceutical Holding Company's "short interest ratio" (SIR) is the quantity of Biohaven Pharmaceutical Holding Company shares currently shorted divided by the average quantity of Biohaven Pharmaceutical Holding Company shares traded daily (recently around 786421.91176471). Biohaven Pharmaceutical Holding Company's SIR currently stands at 6.8. In other words for every 100,000 Biohaven Pharmaceutical Holding Company shares traded daily on the market, roughly 6800 shares are currently held short.

However Biohaven Pharmaceutical Holding Company's short interest can also be evaluated against the total number of Biohaven Pharmaceutical Holding Company shares, or, against the total number of tradable Biohaven Pharmaceutical Holding Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biohaven Pharmaceutical Holding Company's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Biohaven Pharmaceutical Holding Company shares in existence, roughly 80 shares are currently held short) or 0.0934% of the tradable shares (for every 100,000 tradable Biohaven Pharmaceutical Holding Company shares, roughly 93 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Biohaven Pharmaceutical Holding Company.

Find out more about how you can short Biohaven Pharmaceutical Holding Company stock.

Biohaven Pharmaceutical Holding Company share dividends

We're not expecting Biohaven Pharmaceutical Holding Company to pay a dividend over the next 12 months.

Biohaven Pharmaceutical Holding Company share price volatility

Over the last 12 months, Biohaven Pharmaceutical Holding Company's shares have ranged in value from as little as $42.74 up to $100.77. A popular way to gauge a stock's volatility is its "beta".

BHVN.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Biohaven Pharmaceutical Holding Company's is 1.0022. This would suggest that Biohaven Pharmaceutical Holding Company's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Biohaven Pharmaceutical Holding Company overview

Biohaven Pharmaceutical Holding Company Ltd. , a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site